Researchers from Queen’s University Belfast and the University of Leeds, as part of a pan-European partnership, have won the prestigious 2018 European Health Award, for their project entitled ‘The European Cancer Patient’s Bill of Rights: A Catalyst for Change and an empowerment tool for cancer patients across Europe’. The project involves an equal partnership between cancer patients, healthcare professionals and cancer researchers.
The news that the European Cancer Patient’s Bill of Rights has received a top European award is wonderful. This collaborative initiative has patients absolutely at its centre. It is especially pleasing that Professor Lawler collected this award at Gastein, given Northern Ireland’s leadership role in the project.
Margaret Grayson, NCRI Consumer Forum
Cancer knows no borders, so it is important that we work together to develop solutions that address cancer inequalities in all parts of Europe. This initiative highlights the very best of the European collaborative approach, involving over 60 stakeholders from 25 European countries, working together for the benefit of patients. I am immensely proud to be accepting this award, not only on behalf of our team who have worked together over the last five years on this initiative, but also on behalf of the millions of European citizens who are living with and beyond cancer and experiencing cancer inequalities every single day of their lives.
Professor Mark Lawler, Chair in Translational Cancer Genomics CCRCB, Queen’s University Belfast